Kernke v. Menninger Clinic, Inc.

172 F. Supp. 2d 1347, 2001 WL 1478658
CourtDistrict Court, D. Kansas
DecidedNovember 14, 2001
DocketCIV. A. 00-2263-GTV
StatusPublished
Cited by4 cases

This text of 172 F. Supp. 2d 1347 (Kernke v. Menninger Clinic, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Kansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kernke v. Menninger Clinic, Inc., 172 F. Supp. 2d 1347, 2001 WL 1478658 (D. Kan. 2001).

Opinion

MEMORANDUM AND ORDER

VanBEBBER, Chief Judge.

Plaintiffs assert various claims against defendants the Menninger Clinic, Inc., Dr. Edward Eaton, Dr. Joyce Davidson and Dr. Patricia Solbach (“Menninger defendants”) arising from the death of Kenneth Kernke. Plaintiffs advance claims against each of the Menninger defendants for medical malpractice, intentional infliction of emotional distress, false imprisonment, fraudulent misrepresentation, breach of fiduciary duty and wrongful death. Plaintiffs assert an additional claim against the Menninger Clinic for misrepresentation. The case is before the court on the Men-ninger defendants’ motion for partial summary judgment (Doc. 148) and on the Men-ninger defendants’ motion to strike the affidavit of Nelda Ferguson, Ph.D. (Doc. 195). For the reasons set forth below, the Menninger defendants’ motion for summary judgment is granted in part and denied in part and their motion to strike is denied.

I. FACTUAL BACKGROUND

The following facts are either uncontro-verted or are based on the evidence submitted with the summary judgment papers and viewed in the light most favorable to the nonmoving party. Immaterial facts and facts not properly supported by the record are omitted.

Kenneth Kernke, the uncle of plaintiff Brian Kernke and the brother of plaintiff Joseph Kernke, lived with his parents in Oklahoma City, Oklahoma for most of his life. In 1988, Kenneth was diagnosed with schizophrenia. Kenneth was hospitalized several times and placed on several different types of anti-psychotic medication after he was initially diagnosed with schizophrenia.

*1350 Kenneth Kernke’s mother, Blanche Kernke, acted as Kenneth’s primary caretaker and held power of attorney for Ken- . neth’s health care until her death in April 1998. Following Blanche’s death, Brian Kernke obtained power of attorney over Kenneth and assumed primary responsibility for Kenneth’s care. In June 1998, Brian, concerned that he was unable to effectively assist Kenneth with the necessities of daily living, called the Menninger Clinic in Topeka, Kansas to inquire about placing Kenneth in an assisted living program. Shortly thereafter, Kenneth voluntarily admitted himself as an outpatient into Horizon House, the Menninger Clinic’s supervised group living arrangement. 1 Kenneth’s diagnosis at the time of his admission was “Schizophrenia, paranoid type, chronic.” Brian also warned Men-ninger staff prior to Kenneth’s admission that though Kenneth presented no threat of physical harm to others or himself, he was depressed as a result of his mother’s death.

Kenneth Kernke’s physician at Horizon House was Dr. Joyce Davidson. In August 1998, Dr. Davidson referred Kenneth to Dr. Edward Eaton for potential participation in a clinical study of M100907, a new investigational drug for schizophrenia and schizoaffective disorders manufactured by Hoechst Marion Roussel, Inc., the predecessor of Aventis Pharmaceutical Inc. Dr. Davidson and Dr. Patricia Solbach were the co-principal investigators responsible for conducting the clinical study at the Menninger Clinic, which was one of numerous sites in North America participating in the study. Dr. Eaton was a physician at Hope Unit, the Menninger Clinic’s inpatient facility.

After receiving the referral from Dr. Davidson, Dr. Eaton interviewed and reviewed the clinical study protocol with Kenneth Kernke to ensure that Kenneth understood what he was volunteering for. Ultimately, Dr. Eaton believed that Kenneth qualified for participation in and would benefit from the study. As a result, Kenneth signed a Patient Information and Consent Form agreeing to take part in the study on August 10, 1998. Kenneth reviewed the form with Leslie Malone, the M100907 study coordinator, and four days later, Dr. Solbach signed off on the form as the individual ultimately responsible for the informed consent process. Among other things, the informed consent form warned Kenneth of the potential risks and hazards involved in participating in the study, including the worsening of schizophrenic symptoms, depression, suicidal thoughts and the fact that a previous participant had committed suicide. The informed consent form also warned Kenneth that because M100907 was an investiga-tional drug, there might be risks involved in participating in the study that could not be predicted or anticipated.

On August 11, 1998, Kenneth Kernke voluntarily admitted himself as an inpatient to Hope Unit to participate in the M100907 study. Following a two-week “wash out” period during which Kenneth Kernke’s system was cleansed of any previous medications, Kenneth began receiving M100907. Medical records indicate that Kenneth experienced a decline in his condition following his admission into the drug study, including a deepening of his depression, an increase in his psychosis and a worsening of his tardive dyskinesia, a neurological disorder characterized by abnormal voluntary muscle movements. In addition, Kenneth repeatedly informed Menninger staff members and Brian *1351 Kernke that he wanted to return home to Oklahoma City. 2

At 8:00 a.m. on October 12, 1998, Kenneth Kernke walked away from the Men-ninger Clinic while on a return trip from the dining hall with a group of patients being escorted and supervised by Earlene Redmond, a Menninger staff member. After discovering that Kenneth had absconded, Redmond immediately informed Menninger Clinic security, who arrived at 8:22 a.m. Security proceeded to search for Kenneth on the Menninger Clinic grounds and in the immediately apparent areas until 9:50 a.m. After the initial search, the Menninger Clinic placed its staff on “be aware status” for Kenneth, which meant that staff was to stay on alert for Kenneth but was not required to actively search for him. The “be aware status” was part of the clinic’s protocol for voluntary patients such as Kenneth who had eloped from the property. The Menninger Clinic also notified the local sheriff’s department of Kenneth’s disappearance, and the sheriffs department came to the clinic at approximately 5:45 p.m. on October 12 to investigate.

On January 16, 1999, Kenneth Kernke was found dead in a wooded area approximately one mile away from the Menninger Clinic. The Shawnee County, Kansas coroner’s report indicates that Kenneth probably died from exposure. Kenneth was 52 years old at the time of his death.

II. SUMMARY JUDGMENT STANDARDS

Summary judgment is appropriate “if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue of material fact and that the moving party is entitled to judgment as a matter of law.” Fed. R.Civ.P. 56(c). The requirement of a “genuine” issue of fact means that the evidence is such that a reasonable jury could return a verdict for the nonmoving party. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). An issue of fact is “material” if it is essential to the proper disposition of the claim. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hinsdale v. Odonnell
Vermont Superior Court, 2025
Keeler v. Peh
Court of Appeals of Kansas, 2021
Beim v. Hulfish
50 A.3d 42 (New Jersey Superior Court App Division, 2012)
Nichols v. United States
311 F. Supp. 2d 1131 (D. Kansas, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
172 F. Supp. 2d 1347, 2001 WL 1478658, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kernke-v-menninger-clinic-inc-ksd-2001.